CoChat

S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial

Papakostas, George I., Mischoulon, David, Shyu, Irene, Alpert, Jonathan E., Fava, Maurizio · 2010 · American Journal of Psychiatry

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Despite the progressive increase in the number of antidepressants, many patients with major depressive disorder continue to be symptomatic. Clearly, there is an urgent need to develop better tolerated and more effective treatments for this disorder. The use of S-adenosyl methionine (SAMe), a naturally occurring molecule that serves as a methyl donor in human cellular metabolism, as adjunctive treatment for antidepressant nonresponders with major depressive disorder represents one such effort toward novel pharmacotherapy development. METHOD: Participants were 73 serotonin reuptake inhibitor (SRI) nonresponders with major depressive disorder enrolled in a 6-week, double-blind, randomized trial of adjunctive oral SAMe (target dose: 800 mg/twice daily). Patients continued to receive their SRI treatment at a stable dose throughout the 6-week trial. The primary outcome measure for the study was the response rates according to the 17-item Hamilton Depression Rating Scale (HAM-D). RESULTS: The HAM-D response and remission rates were higher for patients treated with adjunctive SAMe (36.1% and 25.8%, respectively) than adjunctive placebo (17.6% versus 11.7%, respectively). The number needed to treat for response and remission was approximately one in six and one in seven, respectively. There was no statistically significant difference in the proportion of SAMe- versus placebo-treated patients who discontinued the trial for any reason (20.6% versus 29.5%, respectively), due to adverse events (5.1% versus 8.8%, respectively), or due to inefficacy (5.1% versus 11.7%, respectively). CONCLUSIONS: These preliminary results suggest that SAMe can be an effective, well-tolerated, and safe adjunctive treatment strategy for SRI nonresponders with major depressive disorder and warrant replication.

Overview

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2009.09081198

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 2

  1. 1994, American Psychiatric Publishing
  2. Alpert JE , Papakostas GI , Mischoulon D : One-carbon metabolism and the treatment of depression: roles of S-adenosyl-l-methionine and folate, in Natural Medications for Psychiatric Disorders: Considering the Alternatives, 2nd ed . Edited by , Mischoulon D , Rosenbaum J . Philadelphia, Lippincott Williams and Wilkins, 2008, pp 68–83

Cited by

See all 328

Metadata

Authors
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M.
Affiliations
Harvard University (US)
Venue
American Journal of Psychiatry
Published
2010-08-01
Volume
167
Issue
8
Pages
942-948
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2164759779
Cited by
297
References
15
Citations by year
2026: 8 · 2025: 4 · 2024: 12 · 2023: 10 · 2022: 11 · 2021: 12 · 2020: 64 · 2019: 8 · 2018: 14 · 2017: 15 · 2016: 17 · 2015: 34 · 2014: 20 · 2013: 21 · 2012: 23
FWCI
15.96
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Mental Health (K23MH069629)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
S-adenosylmethionine, serotonin reuptake inhibitors, major depressive disorder, adjunctive therapy, treatment-resistant depression, adverse events
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Double-Blind Method, Drug Resistance, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, S-Adenosylmethionine, Treatment Outcome, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial. https://app.cochat.ai/papers/10.1176/appi.ajp.2009.09081198
The paper
Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010). S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2009.09081198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.